ESMO Gastrointestinal Oncology – Expedition into a new era of research and better care-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ESMO Gastrointestinal Oncology – Expedition into a new era of research and better care

Published:2023-10 Issue: Volume:1 Page:1-2
ISSN:2949-8198
Container-title:ESMO Gastrointestinal Oncology
language:en
Short-container-title:ESMO Gastrointestinal Oncology

Author:

Ben-Aharon I.,Lordick F.

Publisher

Elsevier BV

Reference6 articles.

1. Association or causation: still more questions than answers in early-onset Gasgtrointestinal cancers;Fontana;ESMO Gastrointestinal Oncology,2023

2. Neoadjuvant immunotherapy for early-stage hepatocellular carcinoma: the arts and science;Chan;ESMO Gastrointestinal Oncology,2023

3. Immune checkpoint inhibition (ICI) in current systemic therapies for hepatocellular carcinoma (HCC);van Bömmel;ESMO Gastrointestinal Oncology,2023

4. ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial;Lee;ESMO Gastrointestinal Oncology,2013

5. Individualizing multi-modality therapy for locally advanced rectal cancer: incorporating new data into practice;Goodman;ESMO Gastrointestinal Oncology,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3